A crude heparin sodium

　　1. [Product Introduction] Polysaccharide biochemical substance extracted from pig small intestinal mucosa is usually in the form of sodium salt, so it is called heparin sodium. Heparin has strong anticoagulant and antithrombotic effect, which is mainly used in clinical anticoagulant and antithrombotic therapy. It is also the raw material for drugs such as low molecular weight heparin.

　　2, character: this product is colorless or light yellow clear liquid.

　　3, heparin sodium injection for disease prevention and treatment of thrombosis or embolism (such as myocardial infarction, thrombophlebitis, pulmonary embolism, etc.), various causes of diffuse intravascular coagulation (DIC), also used in hemodialysis, extracorporeal circulation, catheter, such as microvascular surgery operation and some blood specimens or instrument of anticoagulant treatment.

　　4,Pharmacology and toxicology: Due to the physical and chemical properties of strong negative charge, this product can interfere with many links in the coagulation process, and has anticoagulation effect both in vivo and in vitro. Its mechanism of action is complex, mainly through binding with antithrombin ⅲ (AT- ⅲ) to enhance the inhibition of the activated coagulation factors ⅱ, ⅸ, ⅹ, xi and ⅻ. The consequences include preventing platelet aggregation and destruction, preventing the formation of thrombin activase, preventing prothrombin from becoming thrombin, and inhibiting thrombin, thus preventing fibrinogen from becoming fibrin.

　　B, heparin sodium boutique

　　1. Drug category: anticoagulant drugs and thrombolytic drugs

　　2, character: this product is colorless or light yellow transparent liquid.

　　3. Heparins Manufacturer: Due to the physical and chemical characteristics of strong negative charge, this product can interfere with many links in the coagulation process and has anticoagulation effect both in vivo and in vitro. Its mechanism of action is complex, mainly through binding with antithrombin ⅲ (AT- ⅲ) to enhance the inhibition of the activated coagulation factors ⅱ, ⅸ, ⅹ, xi and ⅻ. The consequences include preventing platelet aggregation and destruction, preventing the formation of thrombin activase, preventing prothrombin from becoming thrombin, and inhibiting thrombin, thus preventing fibrinogen from becoming fibrin.

　　4, heparin sodium injection for disease prevention and treatment of thrombosis or embolism (such as myocardial infarction, thrombophlebitis, pulmonary embolism, etc.), various causes of diffuse intravascular coagulation (DIC), also used in hemodialysis, extracorporeal circulation, catheter, such as microvascular surgery operation and some blood specimens or instrument of anticoagulant treatment.